NCT03729115 A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer Status RECRUITING Phase NA
NCT03726931 FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET Status COMPLETED Phase NA
NCT03726879 A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer Status COMPLETED Phase PHASE3
NCT03726619 e-CHEC-uP: Scaling up an Efficacious Cancer Screening Intervention for Women With Limited English Status COMPLETED Phase NA
NCT03725059 Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03724253 [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) Status TERMINATED Phase PHASE2
NCT03723863 Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy Status TERMINATED Phase NA
NCT03719833 Sentinel Lymph Node Biopsy After Neoadjuvant Treatment in Breast Cancer Patents Status COMPLETED Phase N/A
NCT03719495 Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer Status COMPLETED Phase N/A
NCT03718455 Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes Status TERMINATED Phase NA
NCT03716583 Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer Status COMPLETED Phase PHASE2
NCT03716180 DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03714243 Blood Brain Barrier Disruption (BBBD) Using MRgFUS in the Treatment of Her2-positive Breast Cancer Brain Metastases Status COMPLETED Phase NA
NCT03713255 Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial Status UNKNOWN Phase NA
NCT03712956 CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER Status UNKNOWN Phase PHASE2
NCT03712813 Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors Status COMPLETED Phase NA